Literature DB >> 12356643

Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group.

Robert S Schwartz1, Elazer R Edelman, Andrew Carter, Nicolas Chronos, Campbell Rogers, Keith A Robinson, Ron Waksman, Judah Weinberger, Robert L Wilensky, Donald N Jensen, Bram D Zuckerman, Renu Virmani.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12356643     DOI： 10.1161/01.cir.0000033485.20594.6f

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  42 in total

1.  Methotrexate eluting stents: to modify or cure?

Authors:  A C Morton; J Gunn
Journal:  Heart       Date:  2004-02       Impact factor: 5.994

2.  Sustained Efficacy and Arterial Drug Retention by a Fast Drug Eluting Cross-Linked Fatty Acid Coronary Stent Coating.

Authors:  Natalie Artzi; Abraham R Tzafriri; Keith M Faucher; Geoffrey Moodie; Theresa Albergo; Suzanne Conroy; Scott Corbeil; Paul Martakos; Renu Virmani; Elazer R Edelman
Journal:  Ann Biomed Eng       Date:  2015-08-28       Impact factor: 3.934

3.  In vitro study of drug-eluting stent coatings based on poly(L-lactide) incorporating cyclosporine A - drug release, polymer degradation and mechanical integrity.

Authors:  Katrin Sternberg; Sven Kramer; Claudia Nischan; Niels Grabow; Thomas Langer; Gerhard Hennighausen; Klaus-Peter Schmitz
Journal:  J Mater Sci Mater Med       Date:  2007-03-27       Impact factor: 3.896

4.  A histopathological comparison of different definitions for quantifying in-stent neointimal tissue: implications for the validity of intracoronary ultrasound and optical coherence tomography measurements.

Authors:  Pedro A Lemos; Celso K Takimura; Francisco R M Laurindo; Paulo S Gutierrez; Vera D Aiello
Journal:  Cardiovasc Diagn Ther       Date:  2011-12

5.  In vivo Evaluation of Cenderitide-Eluting Stent (CES) II.

Authors:  Yingying Huang; Xu Wen Ng; Soon Ghim Lim; Horng Haur Chen; John C Burnett; Yin Chiang Freddy Boey; Subbu S Venkatraman
Journal:  Ann Biomed Eng       Date:  2015-07-16       Impact factor: 3.934

6.  Preclinical study of a biodegradable polymer-based stent with abluminal sirolimus release.

Authors:  Celso Kiyochi Takimura; Carlos Augusto Homem M Campos; Pedro Henrique Magualhães Craveiro Melo; Julliana Carvalho Campos; Paulo Sampaio Gutierrez; Thiago Francisco Costa Borges; Luciano Curado; Spero Penha Morato; Francisco Rafael Martins Laurindo; Pedro Alves Lemos Neto
Journal:  Arq Bras Cardiol       Date:  2014-04-17       Impact factor: 2.000

7.  Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent.

Authors:  Jinzhou Zhu; Huizhu Liu; Haipo Cui; Zhirong Tang; Chengli Song; Ruiyan Zhang
Journal:  J Mater Sci Mater Med       Date:  2017-02-14       Impact factor: 3.896

8.  A head to head comparison of XINSORB bioresorbable sirolimus-eluting scaffold versus metallic sirolimus-eluting stent: 180 days follow-up in a porcine model.

Authors:  Li Shen; Yizhe Wu; Lei Ge; Yaojun Zhang; Qibing Wang; Juying Qian; Zhifen Qiu; Junbo Ge
Journal:  Int J Cardiovasc Imaging       Date:  2017-06-21       Impact factor: 2.357

9.  First in vitro and in vivo results of an anti-human CD133-antibody coated coronary stent in the porcine model.

Authors:  Alexander Sedaghat; Jan-Malte Sinning; Kathrin Paul; Gregor Kirfel; Georg Nickenig; Nikos Werner
Journal:  Clin Res Cardiol       Date:  2013-02-10       Impact factor: 5.460

10.  Coronary optical frequency domain imaging (OFDI) for in vivo evaluation of stent healing: comparison with light and electron microscopy.

Authors:  Christian Templin; Martin Meyer; Maja Franziska Müller; Valentin Djonov; Ruslan Hlushchuk; Ivanka Dimova; Stefanie Flueckiger; Peter Kronen; Michele Sidler; Karina Klein; Flora Nicholls; Jelena-Rima Ghadri; Klaus Weber; Dragica Paunovic; Roberto Corti; Simon P Hoerstrup; Thomas F Lüscher; Ulf Landmesser
Journal:  Eur Heart J       Date:  2010-06-05       Impact factor: 29.983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.